or Try an Advanced Search...

    Technical Analysis for AEZS - Aeterna Zentaris Inc

    Grade Last Price % Change Price Change
    D 5.100 -0.97% -0.050
    AEZS closed down 0.97 percent on Friday, October 11, 2024, on 18 percent of normal volume.
    Earnings due: Nov 7
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Flat
    Historical AEZS trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Narrow Range Bar Range Contraction -0.97%
    Outside Day Range Expansion -0.97%
    Boomer Sell Setup Bearish Swing Setup -0.97%
    NR7 Range Contraction -0.97%
    Narrow Range Bar Range Contraction -0.97%
    Inside Day Range Contraction -0.97%
    Shooting Star Candlestick Bearish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Doji - Bearish? Reversal 0.00%
    Older End-of-Day Signals for AEZS ...

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    AEZS Chart by TradingView
    Basic chart:

    Profile

    Aeterna Zentaris Inc Description

    Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The Company's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Company focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The Company's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Pharma Pharmaceutical Clinic Drug Biotechnology Leasing Life Sciences Biopharmaceutical Oncology Drug Development Hormone Macimorelin Peptides

    Is AEZS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 15.13
    52 Week Low 4.64
    Average Volume 1,550
    200-Day Moving Average 9.241
    50-Day Moving Average 6.351
    20-Day Moving Average 5.262
    10-Day Moving Average 5.105
    Average True Range 0.243
    RSI (14) 40.12
    ADX 35.03
    +DI 19.652
    -DI 36.740
    Chandelier Exit (Long, 3 ATRs) 5.121
    Chandelier Exit (Short, 3 ATRs) 5.369
    Upper Bollinger Bands 5.736
    Lower Bollinger Band 4.788
    Percent B (%b) 0.33
    BandWidth 18.012
    MACD Line -0.315
    MACD Signal Line -0.389
    MACD Histogram 0.0743
    Fundamentals Value
    Market Cap 319.66 Million
    Num Shares 62.7 Million
    EPS -0.75
    Price-to-Earnings (P/E) Ratio -6.82
    Price-to-Sales 9.61
    Price-to-Book 1.71
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.100
    Resistance 3 (R3) 5.100 5.100 5.100
    Resistance 2 (R2) 5.100 5.100 5.100 5.100
    Resistance 1 (R1) 5.100 5.100 5.100 5.100 5.100
    Pivot Point 5.100 5.100 5.100 5.100 5.100
    Support 1 (S1) 5.100 5.100 5.100 5.100 5.100
    Support 2 (S2) 5.100 5.100 5.100 5.100
    Support 3 (S3) 5.100 5.100 5.100
    Support 4 (S4) 5.100